115 related articles for article (PubMed ID: 20183445)
1. Data mining and statistically guided clinical review of adverse event data in clinical trials.
Southworth H; O'Connell M
J Biopharm Stat; 2009 Sep; 19(5):803-17. PubMed ID: 20183445
[TBL] [Abstract][Full Text] [Related]
2. Statistical methods to analyze adverse events data of randomized clinical trials.
Siddiqui O
J Biopharm Stat; 2009 Sep; 19(5):889-99. PubMed ID: 20183450
[TBL] [Abstract][Full Text] [Related]
3. Predicting event times in clinical trials when treatment arm is masked.
Donovan JM; Elliott MR; Heitjan DF
J Biopharm Stat; 2006 May; 16(3):343-56. PubMed ID: 16724489
[TBL] [Abstract][Full Text] [Related]
4. Graphical approaches to the analysis of safety data from clinical trials.
Amit O; Heiberger RM; Lane PW
Pharm Stat; 2008; 7(1):20-35. PubMed ID: 17323410
[TBL] [Abstract][Full Text] [Related]
5. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
[TBL] [Abstract][Full Text] [Related]
6. Predicting event times in clinical trials when randomization is masked and blocked.
Donovan JM; Elliott MR; Heitjan DF
Clin Trials; 2007; 4(5):481-90. PubMed ID: 17942464
[TBL] [Abstract][Full Text] [Related]
7. Estimating treatment efficacy over time: a logistic regression model for binary longitudinal outcomes.
Choi L; Dominici F; Zeger SL; Ouyang P
Stat Med; 2005 Sep; 24(18):2789-805. PubMed ID: 16134133
[TBL] [Abstract][Full Text] [Related]
8. Mining pharmacovigilance data using Bayesian logistic regression with James-Stein type shrinkage estimation.
An L; Fung KY; Krewski D
J Biopharm Stat; 2010 Sep; 20(5):998-1012. PubMed ID: 20721787
[TBL] [Abstract][Full Text] [Related]
9. Detecting potential safety issues in clinical trials by Bayesian screening.
Gould AL
Biom J; 2008 Oct; 50(5):837-51. PubMed ID: 18932142
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004).
DuMouchel W; Fram D; Yang X; Mahmoud RA; Grogg AL; Engelhart L; Ramaswamy K
Ann Clin Psychiatry; 2008; 20(1):21-31. PubMed ID: 18297583
[TBL] [Abstract][Full Text] [Related]
11. Bayesian hierarchical modeling for detecting safety signals in clinical trials.
Xia HA; Ma H; Carlin BP
J Biopharm Stat; 2011 Sep; 21(5):1006-29. PubMed ID: 21830928
[TBL] [Abstract][Full Text] [Related]
12. A retrospective analysis of VIOXX in Australia: using clinical trial data and linked administrative health data to predict patient groups at risk of an adverse drug event.
Whitstock MT; Pearce CM; Ridout SC; Eckermann EJ
Aust N Z J Public Health; 2010 Aug; 34(4):431-2. PubMed ID: 20649787
[No Abstract] [Full Text] [Related]
13. Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone.
Dahabreh IJ; Economopoulos K
Clin Trials; 2008; 5(2):116-20. PubMed ID: 18375649
[TBL] [Abstract][Full Text] [Related]
14. Prediction of an outcome using trajectories estimated from a linear mixed model.
Maruyama N; Takahashi F; Takeuchi M
J Biopharm Stat; 2009 Sep; 19(5):779-90. PubMed ID: 20183443
[TBL] [Abstract][Full Text] [Related]
15. [Meta-analysis of the Italian studies on short-term effects of air pollution].
Biggeri A; Bellini P; Terracini B;
Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
[TBL] [Abstract][Full Text] [Related]
16. Continuous safety monitoring for randomized controlled clinical trials with blinded treatment information. Part 2: Statistical considerations.
Ball G; Piller LB
Contemp Clin Trials; 2011 Sep; 32 Suppl 1():S5-7. PubMed ID: 21664986
[TBL] [Abstract][Full Text] [Related]
17. [Controlled randomized clinical trials].
Jaillon P
Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
[TBL] [Abstract][Full Text] [Related]
18. Bayesian inference for randomized clinical trials with treatment failures.
Shaffer ML; Chinchilli VM
Stat Med; 2004 Apr; 23(8):1215-28. PubMed ID: 15083479
[TBL] [Abstract][Full Text] [Related]
19. Bayesian models for subgroup analysis in clinical trials.
Jones HE; Ohlssen DI; Neuenschwander B; Racine A; Branson M
Clin Trials; 2011 Apr; 8(2):129-43. PubMed ID: 21282293
[TBL] [Abstract][Full Text] [Related]
20. Borrowing strength from external trials in a meta-analysis.
Higgins JP; Whitehead A
Stat Med; 1996 Dec; 15(24):2733-49. PubMed ID: 8981683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
